{
    "2015-10-16": [
        "PFE - Valeant Probe Reprises Federal Focus on Drug Pricing",
        "PFE Pfizer, Inc. Short Sales",
        "The First Cancer Immunotherapy ETF",
        "Celator Pharmaceuticals NASDAQ $CPXX $1.78 pps with $18 Price Target",
        "$PFE News Updated Thursday, October 15, 2015 9:11:08 PM"
    ]
}